Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Med-X

Explore full profile

R&d, agriculture, manufacturing and media company expanding the medical and recreational cannabis industry

Los Angeles, United StatesFounded 2014Biotech & Life Sciences
Valuation <$5M Last recorded · 2024
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Med-X and the history behind them.

About Med-X

Med-X, Inc. is a pioneering company that focuses on creating natural and alternative solutions to replace harmful chemicals and pharmaceutical products. The company operates primarily in the pest control, aromatherapy, pain management, and farming sectors. Their flagship product, Nature-Cide, is an all-natural pest control solution, developed through a decade of research. This product line is eco-friendly and safe for use around family and pets, offering a green alternative to traditional insecticides.

In addition to pest control, Med-X also offers a range of heating and cooling packs under the brand Thermal-Aid. These products are designed to alleviate various types of pain, including headaches, muscle soreness, and menstrual pain. They are hand washable, mold resistant, and suitable for both adults and children.

Med-X's business model is consumer-centric, aiming to provide solutions that promote a healthy lifestyle without compromising personal and environmental safety. The company generates revenue through the sale of its products, benefiting not only its customers but also its shareholders and partners. Med-X is committed to ethical and eco-friendly product development, with a focus on plant-based materials.

In summary, Med-X, Inc. is a health and wellness company that offers natural, safe, and effective solutions for pest control, pain management, and more. They are committed to promoting a healthier lifestyle and a safer environment through their innovative products.

Source: Dealroom company data

At a glance

Founded
2014
Headquarters
Los Angeles, United States
Sector
Biotech & Life Sciences

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Newchip
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States90%
🇩🇪 Germany10%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Med-X on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Med-X on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.